title: Targeting CCR4 as an emerging strategy for cancer therapy and vaccines.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, Unité 1138, Paris, F-75006, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Paris 6, UMR S 1138, 15 rue de l'Ecole de Médicine, Paris, F-75006, France; Université Paris Descartes, UMR S 1138 Paris, F-75006, France. Electronic address: jagadeesh.bayry@crc.jussieu.fr.
authors.forename: Jagadeesh
authors.initials: J
authors.lastname: Bayry
authors.affiliation: Institut National de la Santé et de la Recherche Médicale, Unité 970, PARCC (Paris Cardiovascular Research Center), Université Paris Descartes, Sorbonne Paris Cité, 56 rue Leblanc, F-75015, Paris, France; Hôpital Européen Georges-Pompidou, Service d'Immunologie Biologique, AP-HP, F-75015, Paris, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Tartour
authors.affiliation: Epinova Discovery Performance Unit, Immuno-inflammation Therapeutic Area, GlaxoSmithKline, Medicines Discovery Centre, SG1 2NY, Stevenage, UK.
authors.forename: David F
authors.initials: DF
authors.lastname: Tough
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000276:immunology / Q000494:pharmacology*; D006801:Humans; D058990:Molecular Targeted Therapy; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*; D054398:Receptors, CCR4 / Q000037:antagonists & inhibitors* / Q000276:immunology*
chemical_list: D019496:Cancer Vaccines; D054398:Receptors, CCR4